← Eichor
Condition: Tuberous Sclerosis Complex Tsc Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tuberous Sclerosis Complex Tsc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Phase N/A · 1 location(s) · David M. Ritter · NCT06160310A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidne
NA · 2 location(s) · St. James's Hospital, Ireland · NCT07561957Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · 1 location(s) · SAPU NANO (US) LLC · NCT07369505Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06330350Role of Genetic Factors in the Development of Lung Disease
Phase N/A · 2 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001532Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tube
Phase N/A · 1 location(s) · University of Milan · NCT07304856Study of Skin Tumors in Tuberous Sclerosis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001975Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Phase 2 · 7 location(s) · Holland Bloorview Kids Rehabilitation Hospital · NCT06081348Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Phase 3 · 1 location(s) · Oils4Cure · NCT07403266Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2 · 11 location(s) · Darcy Krueger · NCT05104983TSC Biosample Repository and Natural History Database
Phase N/A · 26 location(s) · National Tuberous Sclerosis Association · NCT05676099Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuber
Phase 3 · 2 location(s) · Katarzyna Kotulska · NCT05534672Regulating Together in Tuberous Sclerosis Complex
NA · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06105736National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852ESIS in Pediatric DRE
Phase N/A · 1 location(s) · Sarah Katie Ihnen · NCT05469373Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764602Study of the Disease Process of Lymphangioleiomyomatosis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001465GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Phase N/A · 1 location(s) · Stefan Lujinschi · NCT07575347Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT02890641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.